HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Familial massive tendon xanthomatosis with decreased high-density lipoprotein-mediated cholesterol efflux.

Abstract
We experienced a family with novel massive tendon xanthomatosis which can be excluded from known disease causing xanthomatosis. The proband was a 58-year-old man who had necrosis in his massive Achilles tendon xanthoma. Three of 5 brothers including him and his nephew had the same clinical phenotype. The systemic tendon xanthomatosis became apparent around 30 years of their age. The proband and his elder brother had mild elevations of serum total cholesterol level (251 and 228 mg/dL, respectively). The low-density lipoprotein receptor activity of the proband's lymphocytes was normal. Neither plant sterol nor cholestanol level was increased in the proband's plasma. Magnetic resonance image of the proband's Achilles tendon demonstrated a massive expansion of the soft tissue with salami sausage-like appearance in his heels (50 mm in thickness). The physiological function of macrophages (MPhi) from the patients was investigated to clarify the mechanism for the formation of xanthomatosis. There was no significant difference in the uptake of oxidized low-density lipoprotein between the proband's MPhi and the control. High-density lipoprotein 3-mediated cholesterol efflux from the patients' MPhi (n = 2) was significantly reduced compared with the controls (n = 3), whereas there was no difference in apolipoprotein (apo) A-I-mediated cholesterol efflux between the patients' MPhi and the controls. Furthermore, there was no reduction of the messenger RNA levels of ATP-binding cassette transporter 1 (ABCA1), which is involved in apo A-I-mediated cholesterol efflux, in the proband's MPhi compared with the control. The present study demonstrates that the mechanism for the formation of novel familial massive tendon xanthomatosis may be, at least in part, associated with decreased high-density lipoprotein 3, but not free apo A-I-mediated cholesterol efflux from MPhi in vivo.
AuthorsFumihiko Matsuura, Ken-ichi Hirano, Masahiro Koseki, Tohru Ohama, Akifumi Matsuyama, Ken-ichi Tsujii, Ryutaro Komuro, Makoto Nishida, Naohiko Sakai, Hisatoyo Hiraoka, Tadashi Nakamura, Shizuya Yamashita
JournalMetabolism: clinical and experimental (Metabolism) Vol. 54 Issue 8 Pg. 1095-101 (Aug 2005) ISSN: 0026-0495 [Print] United States
PMID16092061 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ABCA1 protein, human
  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters
  • Apolipoprotein A-I
  • Lipoproteins, HDL
  • Lipoproteins, HDL3
  • Cholesterol
Topics
  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters (genetics, metabolism)
  • Achilles Tendon (metabolism, pathology)
  • Apolipoprotein A-I (metabolism)
  • Cells, Cultured
  • Cholesterol (metabolism)
  • Humans
  • Lipoproteins, HDL (metabolism)
  • Lipoproteins, HDL3
  • Macrophages (cytology, metabolism)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Monocytes (cytology, metabolism)
  • Pedigree
  • Wolman Disease (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: